Biolife Solutions Inc
BLFS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.69B
Close$
$-1.25
103.6% downside
Current Fair Value
103.6% downsideOvervalued by 103.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.69 Billion |
|---|---|
| Enterprise Value | $1.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.25 |
| Beta | 1.94 |
| Outstanding Shares | 48,866,822 |
Return
| Return on Equity | 12.01% |
|---|---|
| Return on Assets | 11.27% |
| Return on Invested Capital | 1.59% |
Valuation & Multiples
| P/E Ratio | 33.52 |
|---|---|
| PEG | -8.71 |
| Price to Sales | 17.49 |
| Price to Book Ratio | 4.37 |
| Enterprise Value to Revenue | 16.39 |
| Enterprise Value to EBIT | 243.69 |
| Enterprise Value to Net Income | 33 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$27.80 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$29.17 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 29.33%▼ 75.13% |
|---|---|
| Total Invested | $400.95M▼ 57.87% |
| Investors Holding | 81▼ 106.00% |
ESG Score
No data
About Biolife Solutions Inc
CEO: Michael Rice